Compare GODAVARI DRU with SAMRAT PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GODAVARI DRU vs SAMRAT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GODAVARI DRU SAMRAT PHARMA GODAVARI DRU/
SAMRAT PHARMA
 
P/E (TTM) x 9.5 18.7 51.0% View Chart
P/BV x 1.9 4.3 44.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 GODAVARI DRU   SAMRAT PHARMA
EQUITY SHARE DATA
    GODAVARI DRU
Mar-21
SAMRAT PHARMA
Mar-21
GODAVARI DRU/
SAMRAT PHARMA
5-Yr Chart
Click to enlarge
High Rs60159 37.7%   
Low Rs1058 16.6%   
Sales per share (Unadj.) Rs162.9497.3 32.8%  
Earnings per share (Unadj.) Rs5.517.3 31.8%  
Cash flow per share (Unadj.) Rs7.118.9 37.7%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs32.495.9 33.8%  
Shares outstanding (eoy) m7.533.09 243.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.20.2 97.8%   
Avg P/E ratio x6.36.3 100.9%  
P/CF ratio (eoy) x4.95.8 85.0%  
Price / Book Value ratio x1.11.1 94.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m262335 78.1%   
No. of employees `000NANA-   
Total wages/salary Rs m3911 374.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,2271,537 79.8%  
Other income Rs m45 88.6%   
Total revenues Rs m1,2311,541 79.9%   
Gross profit Rs m9887 113.7%  
Depreciation Rs m125 248.1%   
Interest Rs m3313 260.1%   
Profit before tax Rs m5773 77.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1620 78.5%   
Profit after tax Rs m4153 77.4%  
Gross profit margin %8.05.6 142.5%  
Effective tax rate %27.727.4 101.0%   
Net profit margin %3.43.5 97.0%  
BALANCE SHEET DATA
Current assets Rs m676473 142.9%   
Current liabilities Rs m505273 184.8%   
Net working cap to sales %13.913.0 107.1%  
Current ratio x1.31.7 77.3%  
Inventory Days Days12 62.4%  
Debtors Days Days134,256,17778,397,170 171.3%  
Net fixed assets Rs m235101 233.6%   
Share capital Rs m7531 243.7%   
"Free" reserves Rs m169265 63.5%   
Net worth Rs m244296 82.3%   
Long term debt Rs m1450-   
Total assets Rs m911574 158.8%  
Interest coverage x2.76.8 40.3%   
Debt to equity ratio x0.60-  
Sales to assets ratio x1.32.7 50.3%   
Return on assets %8.211.5 71.0%  
Return on equity %16.918.0 94.1%  
Return on capital %23.229.1 79.8%  
Exports to sales %1.08.9 11.3%   
Imports to sales %62.186.8 71.5%   
Exports (fob) Rs m12137 9.0%   
Imports (cif) Rs m7611,334 57.1%   
Fx inflow Rs m12137 9.0%   
Fx outflow Rs m7611,334 57.1%   
Net fx Rs m-749-1,198 62.6%   
CASH FLOW
From Operations Rs m1348 27.5%  
From Investments Rs m-13-29 42.8%  
From Financial Activity Rs m1-19 -7.1%  
Net Cashflow Rs m20 1,009.5%  

Share Holding

Indian Promoters % 56.1 49.7 113.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.5 3.2 15.4%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 43.9 50.4 87.1%  
Shareholders   5,750 4,846 118.7%  
Pledged promoter(s) holding % 5.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GODAVARI DRU With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex Corrects Over 1,000 Points as Fed Signals Rate Hike; Realty & IT Stocks Bleed(10:30 am)

Asian stock markets fell sharply today, tracking losses across Asia and Wall Street after Federal Reserve chief Jerome Powell confirmed the bank will lift interest rates in March.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GODAVARI DRU SHARE PRICE


Jan 27, 2022 11:44 AM

TRACK GODAVARI DRU

  • Track your investment in GODAVARI DRU with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GODAVARI DRU - MOREPEN LABS COMPARISON

COMPARE GODAVARI DRU WITH

MARKET STATS